Founded in the United States, AngioDynamics is committed to improving patient outcomes through the development of disruptive and differentiated medical technologies. The company focuses on addressing unmet patient needs in vascular, peripheral vascular, and oncology medicine. AngioDynamics offers a range of innovative medical devices designed to elevate the standard of care for both chronic and acute disease states, thereby supporting healthcare professionals globally in delivering high-quality patient care.
Notable achievements include the CE Mark approval in Europe for their AlphaVac F18 system, which underscores their commitment to innovation and regulatory excellence. AngioDynamics' impact is significant, providing essential tools that enhance the capabilities of healthcare providers and improve patient outcomes worldwide. The company's dedication to advancing medical technology has positioned it as a key player in the medical device industry, driving forward the quality and effectiveness of patient care.
